A team of CiRA researchers has uncovered the crucial role of EIF3D—a protein translational regulator—in primed pluripotency.

A Peninsula biotech company raised $68 million from investors — including a venture philanthropy fund started by Lululemon Athletica founder Chip Wilson — to push a next-generation CRISPR drug ...

EPI-321, the startup’s lead program, uses CRISPR tools to stop errant expression of a gene implicated in the muscle-wasting condition. Epicrispr will start a Phase 1 trial this year in New Zealand, ...

Advances in the gene-editing technology known as CRISPR-Cas9 over the past 15 years have yielded important new insights into the roles that specific genes play in many diseases. But to date this ...

Advances in the gene-editing technology known as CRISPR-Cas9 over the past 15 years have yielded important new insights into the roles that specific genes play in many diseases. But to date this ...

Advances in the gene-editing technology known as CRISPR-Cas9 over the past 15 years have yielded important new insights into the roles that specific genes play in many diseases. But to date this ...

Resultantly, developments of recombinant viral vectors with improved transduction efficiency and further methodological improvements have mostly focused on murine tissue, whereas AAVs successfully ...

Ar­bor Biotech­nolo­gies, a start­up found­ed by CRISPR pi­o­neer Feng Zhang nine years ago, has closed a $73.9 mil­lion Se­ries C fi­nanc­ing to bring its first … ...

As the race between U.S. and Chinese biotech companies heats up, the competition is particularly fierce in one field: CRISPR gene editing. China has rapidly emerged as a global leader in CRISPR ...

New CRISPR-Cas systems have been identified, enhancing the gene editing toolkit. A notable system, SubCas9, from bacteria in dairy cows, is efficient, small, and can target unique gene sequences ...